Sera from HD patients and controls were analyzed for specific anti-SARS-CoV-2-spike antibodies (IgG, IgM, and IgA) using an ELISA calibrated with sera collected prior COVID-19 pandemic and from COVID-19 patients. This evidence concerns the gene CD79A and Huntington disease.